Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Luping Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Basic Public Welfare Research Program of Zhejiang Province, the Key R&D Program of Zhejiang.
Abstract (Originalsprache)
Capilliposide B (CPS‐B), a novel oleanane triterpenoid saponin derived from Lysimachia capillipes Hemsl, is a potent anticancer agent. However, its anticancer mechanism remains elusive. In the present study, we demonstrated the potent anti‐tumor activity and molecular mechanism of CPS‐B both in vitro and in vivo. Proteomic analysis using isobaric tags for relative and absolute quantitation techniques suggested that CPS‐B modulated autophagy in prostate cancer (PC). Moreover, Western blotting showed that both autophagy and epithelial–mesenchymal transition occurred place after CPS‐B treatment in vivo, which was also proven in PC‐3 cancer cells. We deduced that CPS‐B inhibited migration by inducing autophagy. We examined the accumulation of reactive oxygen species (ROS) in cells, and in downstream pathways, LKB1 and AMPK were activated while mTOR was inhibited. Transwell experiment results showed that CPS‐B inhibited the metastasis of PC‐3 cells and that this effect was significantly attenuated after pretreatment with chloroquine, indicating that CPS‐B inhibited metastasis via autophagy induction. Altogether, these data suggest that CPS‐B is a potential therapeutic agent for cancer treatment that acts by inhibiting migration through the ROS/AMPK/mTOR signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, People's Republic of China.
- Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
- Marine Science College, Zhejiang Ocean University, Zhoushan, Zhejiang, People's Republic of China.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, People's Republic of China.
ORCID-Profile: Luping Wang
Förderung
- Basic Public Welfare Research Program of Zhejiang Province
- the Key R&D Program of Zhejiang
Zitieren
APA
Wang, L., Han, H., Feng, Y., Ma, J., Han, Z., Li, R., Zhu, W., Li, S., Tian, J., & Zhang, L. (2023). Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7785
Vancouver
Wang L, Han H, Feng Y, Ma J, Han Z, Li R, et al. Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7785
BibTeX
@article{Wang2023,
author = {Wang, Luping and Han, Haote and Feng, Yue and Ma, Jiahui and Han, Zhuo and Li, Ruyi and Zhu, Wei and Li, Shouxin and Tian, Jingkui and Zhang, Lin},
title = {Capilliposide B inhibits the migration of prostate cancer by inducing autophagy through the ROS / AMPK / mTOR pathway},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7785}
}
EUVIMED